Issue IndexA searchable index of tables of contents
Find An Issue
Table of contents for
July 8, 2004 Vol. 351 No. 2
- Free Full Text
This prospective study found that the risk of death from prostate cancer after radical prostatectomy was related to the rate of rise in the level of prostate-specific antigen (PSA) — the PSA velocity — during the year before the diagnosis of prostate cancer, the PSA level at the time of diagnosis, the clinical tumor stage, and the Gleason score. A velocity of at least 2.0 ng per milliliter during the year before the diagnosis augured a high risk of death despite radical prostatectomy.
- Free Full Text
In a randomized trial of women with severe twin-to-twin transfusion syndrome during midgestation, fetoscopic laser therapy (coagulation of placental vascular anastomoses) resulted in significantly higher survival rates of at least one twin and lower rates of neurologic abnormalities at six months of age than did amnioreduction (repeated removal of large volumes of amniotic fluid).
- Free Full Text
Doxorubicin is an efficacious treatment for childhood acute lymphoblastic leukemia (ALL), but it is toxic to myocardial cells and can cause cardiomyopathy. In this clinical trial, dexrazoxane, a free-radical scavenger, was found to reduce doxorubicin-induced myocardial injury, as indicated by cardiac troponin T levels before, during, and after therapy.
- Free Full Text
An HIV-infected patient in San Francisco with primary syphilis was treated with azithromycin, but the lesion did not resolve. The authors of this case report confirmed resistance to azithromycin and identified a mutation in the 23S rRNA genes of T. pallidum. The mutation was also found in samples collected in Baltimore, Seattle, and Dublin.
This patient presented at the age of 55 years with prostate cancer, detected because of urinary symptoms and a rising prostate-specific antigen (PSA) level. He was well for seven years after local radiation therapy and androgen-deprivation treatment; then his PSA level began to rise, and metastatic lesions were detected. The care of this patient necessitated consideration of treatment options for patients with localized and advanced prostate cancer and hormone-refractory disease.
- Free Full Text
- Free Full Text
- Free Full Text
- Free Full Text
- Free Full Text
- Free Full Text
- Free Full Text
- Free Full Text





